Top Story

Zoledronic acid improved bone health in patients with osteoporosis

May 3, 2016

Use of zoledronic acid for the treatment of osteoporosis enhanced bone mineral density and reduced bone turnover in patients, according to results.

Overall, 154 adult patients (149 women) with osteoporosis were treated between January 2008 and December 2011 with a once-yearly 5 mg dose of zoledronic acid intravenously. The percentage change in bone mineral density (BMD) from baseline after 12 months of zoledronic acid treatment was the primary efficacy endpoint.

In the Journals

Sugaya MRI classification showed no differences between intact rotator cuff repair, partial-thickness retears

May 3, 2016
Recently published results showed no significant differences in clinical scores between patients with intact rotator cuff repairs or partial-thickness retears as…
Meeting News CoverageVideo

VIDEO: A look at surgical vs non-surgical management of elbow arthritis in young athletes

May 3, 2016
ORLANDO, Fla. — At the American Academy of Orthopaedic Surgeons Annual Meeting, Mandeep Virk, MD, spoke about both surgical and non-surgical techniques to treat…
Meeting News Coverage

Patients with longer vertebral augmentation procedures have poorer postoperative quality of life, study finds

May 3, 2016
CHICAGO — Among pain-related and depression-related quality of life measures, longer operative time, younger age and increased time from fracture to surgery were…
Meeting News Coverage

Study: Postoperative infection after ACDF is low

May 3, 2016
CHICAGO — The incidence of postoperative infection after anterior cervical discectomy and fusion is low, according to data presented here at the American…
More News Headlines »